Adenovirus-mediated REIC/Dkk-3 gene transfer as a new gene therapeutic approach for prostate cancer

Research output: Contribution to journalArticlepeer-review


It has been reported that REIC/Dkk-3, a member of the Dickkopf (Dkk) gene family, works as a tumor suppressor. We evaluated the therapeutic effects of an intratumoral injection with adenoviral vector encoding REIC/Dkk-3 gene (Ad-REIC) using our animal model including subcutaneous tumor model of PC-3 cells and orthotopic mouse prostate cancer model of RM-9 cells. We also investigated the in vivo anti-metastatic effect and in vitro anti-invasion effect of Ad-REIC gene delivery. We demonstrated that the Ad-REIC treatment inhibited prostate cancer growth and lymph node metastasis, and prolonged mice survival in the model. These therapeutic responses were consistent with the intratumoral apoptosis induction and in vitro suppression of cell invasion/migration with reduced matrix metalloprotease-2 activity. We thus concluded that in situ Ad-REIC/Dkk-3 gene transfer may be a promising therapeutic intervention for the treatment of prostate cancer.

Original languageEnglish
Pages (from-to)685-692
Number of pages8
JournalNishinihon Journal of Urology
Issue number12
Publication statusPublished - Dec 2007


  • Dkk-3
  • Metastasis
  • Prostate cancer
  • REIC

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Adenovirus-mediated REIC/Dkk-3 gene transfer as a new gene therapeutic approach for prostate cancer'. Together they form a unique fingerprint.

Cite this